Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs
Andrew Lofts, Fahed Abu-Hijleh, Nicolette Rigg, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 739-770
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 52
Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery
Rebecca Maher, Almudena Moreno-Borrallo, Dhruvi Jindal, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 746-746
Open Access | Times Cited: 34
Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders
Margarida Alberto, Ana Cláudia Paiva‐Santos, Francisco Veiga, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2742-2742
Open Access | Times Cited: 30
Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders
Elizabeth J. Patharapankal, Adejumoke Lara Ajiboye, Claudia Mattern, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 66-66
Open Access | Times Cited: 19
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
Lauren Arms, Ryan J. Duchatel, Evangeline R. Jackson, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 835-865
Open Access | Times Cited: 6
In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route
Arya Ghosh, Ankit Majie, Varnita Karmakar, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access | Times Cited: 5
Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature
Angela Bonaccorso, Alessandro Ortis, Teresa Musumeci, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5619-5636
Open Access | Times Cited: 5
Intranasal Administrations of AP39-Loaded Liposomes Selectively Deliver H2S to Neuronal Mitochondria to Protect Neonatal Hypoxia–Ischemia by Targeting ERK1/2 and Caspase-1
Yan Song, N. Li, Qian Luo, et al.
ACS Biomaterials Science & Engineering (2025)
Closed Access
Nano-formulated curcumin uptake and biodistribution in the fetal growth restricted newborn piglet brain
Nuo Xu, Julie A. Wixey, Kirat K. Chand, et al.
Drug Delivery and Translational Research (2025)
Closed Access
The Impact of Preoperative Low-Dose Esketamine and Dexmedetomidine Nasal Administration on the Emergence Delirium in Children Undergoing Fiber Bronchoscopy: A Prospective Randomized Controlled Trial
Wei Xie, Le Wang, Zhe Peng, et al.
Clinical Neuropharmacology (2025)
Closed Access
The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
Ludivine Boudieu, M. Mennetrier, Pierre‐Michel Llorca, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2773-2773
Open Access | Times Cited: 12
Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers
Stuart Madden, Enrique Carrazana, Adrián L. Rabinowicz
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2119-2119
Open Access | Times Cited: 11
In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders
Andrew Lofts, Matthew A. Campea, Erica Winterhelt, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134385-134385
Open Access | Times Cited: 4
Hyaluronic Acid-Based Hybrid Nanoparticles as Promising Carriers for the Intranasal Administration of Dimethyl Fumarate
Carla Serri, M. Piccioni, Vincenzo Guarino, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 71-89
Open Access
Visualizing the spatial distribution of Alprazolam in the mouse brain following nasal administration using desorption electrospray ionization mass spectrometry imaging
Xiujiao Xia, Yi Zhang, Guixiang Yang, et al.
International Journal of Pharmaceutics (2025), pp. 125185-125185
Closed Access
Vitamins as excipients in pharmaceutical products
Anne-Cécile V. Bayne, Jenni Pessi, Julia K. Bird, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107020-107020
Open Access
Fear extinction induced by activation of PKA ameliorates anxiety-like behavior in PTSD mice
Feng Gao, Juan Wang, Shaojie Yang, et al.
Neuropharmacology (2022) Vol. 222, pp. 109306-109306
Closed Access | Times Cited: 18
Current and future directions of drug delivery for the treatment of mental illnesses
Parker Brewster, Saif Mohammad Ishraq Bari, Glenn M. Walker, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114824-114824
Open Access | Times Cited: 10
Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis
Hsiangkuo Yuan, Aniket Natekar, Jade Park, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 12, pp. 581-587
Closed Access | Times Cited: 9
Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport
Shivam Singh, Kunal Khurana, Shikha Baghel Chauhan, et al.
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review
Tolga Dittrich, Dominik Vock, Urs Fisch, et al.
Neurocritical Care (2024) Vol. 41, Iss. 2, pp. 632-650
Open Access | Times Cited: 3
Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects
Farhan Mazahir, Md Imtiyaz Alam, Awesh K. Yadav
Ageing Research Reviews (2024) Vol. 98, pp. 102318-102318
Closed Access | Times Cited: 3
Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures：a prospective cohort study
Jing Wang, Jie Zeng, Nan Zhao, et al.
International Journal of Surgery (2023) Vol. Publish Ahead of Print
Open Access | Times Cited: 7
Tissue-based in vitro and ex vivo models for nasal permeability studies
Natalia N. Porfiryeva, Alejandro Sosnik
Elsevier eBooks (2024), pp. 347-371
Closed Access | Times Cited: 2
Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases
Shaza S. Issa, Haidar Fayoud, Alisa Shaimardanova, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1906-1906
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top